Athena Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 27-07-2024
- Paid Up Capital ₹ 0.10 M
as on 27-07-2024
- Company Age 15 Year, 8 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.60 M
as on 27-07-2024
- Revenue -20.71%
(FY 2023)
- Profit 41.25%
(FY 2023)
- Ebitda 52.86%
(FY 2023)
- Net Worth 16.90%
(FY 2023)
- Total Assets -26.65%
(FY 2023)
About Athena Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.60 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vikrant Singh and Dhruvaraj Singh serve as directors at the Company.
- CIN/LLPIN
U85100MH2009PTC197868
- Company No.
197868
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Athena Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikrant Singh  | Director | 15-Dec-2009 | Current |
| Dhruvaraj Singh | Director | 18-May-2012 | Current |
Financial Performance of Athena Pharma.
Athena Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.71% decrease. The company also saw a substantial improvement in profitability, with a 41.25% increase in profit. The company's net worth Soared by an impressive increase of 16.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Athena Pharma?
In 2023, Athena Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Oct 2021 | ₹1.60 M | Satisfied |
How Many Employees Work at Athena Pharma?
Unlock and access historical data on people associated with Athena Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Athena Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Athena Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
